A systematic review of antiproton radiotherapy
Abstract: Antiprotons have been proposed as possible particles for radiotherapy; over the past years, the renewed interest in the potential biomedical relevance led to an increased research activity. It is the aim of this review to deliver a comprehensive overview regarding the evidence accumulated so far, analysing the background and depicting the current status of antiprotons in radiotherapy. A literature search has been conducted, including major scientific and commercial databases. All articles and a number of relevant conference abstracts published in the respective field have been included in this systematic review. The physical basis of antiproton radiotherapy is complex; however, the characterization of the energy deposition profile supports its potential use in radiotherapy. Also the dosimetry improved considerably over the past few years. Regarding the biological properties, data on the effects on cells are presented; however, definite conclusions regarding the relative biological effectiveness cannot be made at the moment and radiobiological evidence of enhanced effectiveness remains scarce. There is new evidence supporting the potential imaging properties, for example for online dose verification. Clinical settings which might profit from the use of antiprotons have been further tracked. Judging from the evidence available so far, clinical constellations requiring optimal sparing in the entrance region of the beam and re-irradiations might profit most from antiproton radiotherapy. While several open questions remain to be answered, first steps toward a thorough characterization of this interesting modality have been made
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
Frontiers in physics. 1 (2013), 37, DOI 10.3389/fphy.2013.00037, issn: 2296-424X
IN COPYRIGHT http://rightsstatements.org/page/InC/1.0 rs
- Keyword
-
Antiproton
Therapie
Hadron
Strahlenbiologie
Nichtmedikamentöse Therapie
- Event
-
Veröffentlichung
- (where)
-
Freiburg
- (who)
-
Universität
- (when)
-
2013
- DOI
-
10.3389/fphy.2013.00037
- URN
-
urn:nbn:de:bsz:25-freidok-119709
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:52 PM CET
Data provider
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
Time of origin
- 2013
Other Objects (12)
Stereotaktische Strahlentherapie am adaptierten Linearbeschleuniger bei Patienten mit Hirnmetastasen
Fünfzehn-Jahres Ergebnisse nach Monitoring, Operation oder Strahlentherapie aufgrund eines Prostatakarzinoms : = Fifteen-year outcomes after monitoring, surgery, or radiotherapy for prostate cancer
Genomic classifiers in personalized prostate cancer radiotherapy approaches – a systematic review and future perspectives based on international consensus
Personalized radiotherapy of brain metastases: survival prediction by means of dichotomized or differentiated blood test results?
Short survival time after palliative whole brain radiotherapy: can we predict potential overtreatment by use of a nomogram?
Personalized treatment of brain metastases: evolving survival prediction models may benefit from evaluation of serum tumor markers (narrative review)
Das Rezidivmuster nach perkutaner Strahlentherapie mit und ohne zusätzliche fokale Dosiseskalation innerhalb der randomisierten FLAME-Studie für das lokale Prostatakarzinom
10-Jahres-Letalität, Krankheitsprogress und behandlungsassoziierte Nebenwirkungen bei Männern mit lokalisiertem Prostatakarzinom aus der randomisierten, kontrollierten ProtecT-Studie, analysiert nach erhaltener Therapie : = [10-Year mortality, disease progression, and treatment-related side effects in men with localized prostate cancer from the ProtecT Randomised Controlled Trial, analyzed according to treatment received]
Target volume definition in radiation oncology
A machine learning approach for predicting biochemical outcome after PSMA-PET–guided salvage radiotherapy in recurrent prostate cancer after radical prostatectomy: retrospective study
Incidence of hippocampal and perihippocampal brain metastases and impact on hippocampal-avoiding radiotherapy: a systematic review and meta-analysis
Radiomics-based prediction of local control in patients with brain metastases following postoperative stereotactic radiotherapy
Stereotaktische Strahlentherapie am adaptierten Linearbeschleuniger bei Patienten mit Hirnmetastasen
Fünfzehn-Jahres Ergebnisse nach Monitoring, Operation oder Strahlentherapie aufgrund eines Prostatakarzinoms : = Fifteen-year outcomes after monitoring, surgery, or radiotherapy for prostate cancer
Genomic classifiers in personalized prostate cancer radiotherapy approaches – a systematic review and future perspectives based on international consensus
Personalized radiotherapy of brain metastases: survival prediction by means of dichotomized or differentiated blood test results?
Short survival time after palliative whole brain radiotherapy: can we predict potential overtreatment by use of a nomogram?
Personalized treatment of brain metastases: evolving survival prediction models may benefit from evaluation of serum tumor markers (narrative review)
Das Rezidivmuster nach perkutaner Strahlentherapie mit und ohne zusätzliche fokale Dosiseskalation innerhalb der randomisierten FLAME-Studie für das lokale Prostatakarzinom
10-Jahres-Letalität, Krankheitsprogress und behandlungsassoziierte Nebenwirkungen bei Männern mit lokalisiertem Prostatakarzinom aus der randomisierten, kontrollierten ProtecT-Studie, analysiert nach erhaltener Therapie : = [10-Year mortality, disease progression, and treatment-related side effects in men with localized prostate cancer from the ProtecT Randomised Controlled Trial, analyzed according to treatment received]
Target volume definition in radiation oncology
A machine learning approach for predicting biochemical outcome after PSMA-PET–guided salvage radiotherapy in recurrent prostate cancer after radical prostatectomy: retrospective study
Incidence of hippocampal and perihippocampal brain metastases and impact on hippocampal-avoiding radiotherapy: a systematic review and meta-analysis
Radiomics-based prediction of local control in patients with brain metastases following postoperative stereotactic radiotherapy
Stereotaktische Strahlentherapie am adaptierten Linearbeschleuniger bei Patienten mit Hirnmetastasen
Fünfzehn-Jahres Ergebnisse nach Monitoring, Operation oder Strahlentherapie aufgrund eines Prostatakarzinoms : = Fifteen-year outcomes after monitoring, surgery, or radiotherapy for prostate cancer
Genomic classifiers in personalized prostate cancer radiotherapy approaches – a systematic review and future perspectives based on international consensus
Personalized radiotherapy of brain metastases: survival prediction by means of dichotomized or differentiated blood test results?
Short survival time after palliative whole brain radiotherapy: can we predict potential overtreatment by use of a nomogram?
Personalized treatment of brain metastases: evolving survival prediction models may benefit from evaluation of serum tumor markers (narrative review)
Das Rezidivmuster nach perkutaner Strahlentherapie mit und ohne zusätzliche fokale Dosiseskalation innerhalb der randomisierten FLAME-Studie für das lokale Prostatakarzinom
10-Jahres-Letalität, Krankheitsprogress und behandlungsassoziierte Nebenwirkungen bei Männern mit lokalisiertem Prostatakarzinom aus der randomisierten, kontrollierten ProtecT-Studie, analysiert nach erhaltener Therapie : = [10-Year mortality, disease progression, and treatment-related side effects in men with localized prostate cancer from the ProtecT Randomised Controlled Trial, analyzed according to treatment received]
Target volume definition in radiation oncology
A machine learning approach for predicting biochemical outcome after PSMA-PET–guided salvage radiotherapy in recurrent prostate cancer after radical prostatectomy: retrospective study
Incidence of hippocampal and perihippocampal brain metastases and impact on hippocampal-avoiding radiotherapy: a systematic review and meta-analysis